Federal University of São Paulo
501
8
21
309
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
3.8%
19 terminated/withdrawn out of 501 trials
94.2%
+7.6% vs industry average
23%
113 trials in Phase 3/4
7%
22 of 309 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (501)
Multiple Interventions With Distinct Anti-reservoir Activities in People on Antiretroviral Treatment
Role: lead
Acupuncture Versus Conventional Treatment for Chronic Pain in Patients With Chronic Kidney Disease
Role: lead
Effect of CPAP on Recovery in High-Performance Endurance Athletes
Role: lead
Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race
Role: lead
Photobiomodulation in Coronary Artery Bypass Grafting With No-Touch vs Conventional Saphenous Vein Harvesting.
Role: lead
Exercise Training and Kidney Transplantation
Role: collaborator
Parasitic Ulcer Treatment Trial
Role: collaborator
Validation of MoCA-B and MoCA-Blind for Screening Cognitive Decline
Role: collaborator
Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)
Role: collaborator
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Role: collaborator
Social Transfers for Exclusive Breastfeeding in Brazil
Role: collaborator
Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals
Role: lead
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
Role: collaborator
RB-PDT for Fusarium Keratitis: The LUMIERE Study
Role: collaborator
Effect of Nonsteroidal Anti-Inflammatory Drug Restriction on the Efficacy of Platelet-Rich Plasma in Knee Osteoarthritis
Role: lead
Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil
Role: lead
HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil
Role: lead
Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV
Role: lead
Correlation Between the R-R Interval of the Electrocardiogram and the Intracranial Pulse Wave Interval Assessed by a Noninvasive Method in Healthy People
Role: lead
TMS Combined With Virtual Reality and Multidisciplinary Rehabilitation in Multiple Sclerosis
Role: collaborator